Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...